DISITAMAB VEDOTIN for Bladder cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where DISITAMAB VEDOTIN was used for Bladder cancer.
Most Reported Side Effects for DISITAMAB VEDOTIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 12 | 21.4% | 0 | 9 |
| Off label use | 8 | 14.3% | 0 | 3 |
| White blood cell count decreased | 7 | 12.5% | 0 | 4 |
| Nausea | 5 | 8.9% | 0 | 1 |
Other Indications for DISITAMAB VEDOTIN
Other Drugs Used for Bladder cancer
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279)
PEMBROLIZUMAB (869)
GEMCITABINE (841)
CISPLATIN (780)
ENFORTUMAB VEDOTIN-EJFV (530)
NIVOLUMAB (512)
ATEZOLIZUMAB (487)
CARBOPLATIN (332)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326)
GEMCITABINE\GEMCITABINE (240)